Therapeutic molecular targets of SSc-ILD
Journal of Scleroderma and Related Disorders · 2020-03 · 5 (2_suppl) · 17-30
DOI: 10.1177/2397198319899013 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Scleroderma and Related Disorders, online erschienen am 22.01.2020. Verfasst von Yun Zhang und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine 3-Rheumatology and Immunology, University Hospital Erlangen, University of Erlangen-Nuremberg, Erlangen, Germany. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 170 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Systemic sclerosis is a fibrosing chronic connective tissue disease of unknown etiology. A major hallmark of systemic sclerosis is the uncontrolled and persistent activation of fibroblasts, which release excessive amounts of extracellular matrix, lead to organ dysfunction, and cause high mobility and motility of patients. Systemic sclerosis–associated interstitial lung disease is one of the most common fibrotic organ manifestations in systemic sclerosis and a major cause of death. Treatment options for systemic sclerosis–associated interstitial lung disease and other fibrotic manifestations, however, remain very limited. Thus, there is a huge medical need for effective therapies that target tissue fibrosis, vascular alterations, inflammation, and autoimmune disease in systemic sclerosis–associated interstitial lung disease. In this review, we discuss data suggesting therapeutic ways to target different genes in distinct tissues/organs that contribute to the development of SSc.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Internal Medicine 3-Rheumatology and Immunology, University Hospital Erlangen, University of Erlangen-Nuremberg, Erlangen, Germany.
ORCID-Profile: Yun Zhang, Jörg Hw Distler
Zitieren
APA
Zhang, Y., & Distler, J. H. (2020). Therapeutic molecular targets of SSc-ILD. Journal of Scleroderma and Related Disorders, 5(2_suppl), 17-30. https://doi.org/10.1177/2397198319899013
Vancouver
Zhang Y, Distler JH. Therapeutic molecular targets of SSc-ILD. Journal of Scleroderma and Related Disorders. 2020;5(2_suppl):17-30. doi:10.1177/2397198319899013
BibTeX
@article{Zhang2020,
author = {Zhang, Yun and Distler, Jörg Hw},
title = {Therapeutic molecular targets of SSc-ILD},
journal = {Journal of Scleroderma and Related Disorders},
year = {2020},
volume = {5},
number = {2_suppl},
pages = {17--30},
doi = {10.1177/2397198319899013}
}
EUVIMED